Lushang Freda Pharmaceutical Co (SHSE:600223) Institutional Ownership: 1.69% (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600223 Lushang Freda Pharmaceutical Co Ltd SHSE:600223
73 GF Score
Price ¥5.75
GF Value ¥6.77
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lushang Freda Pharmaceutical Co Institutional Ownership?

Lushang Freda Pharmaceutical Co SHSE:600223 +0.70% 73 Institutional Ownership is 1.69% as of Aug. 28, 2026. GuruFocus rates SHSE:600223 with a GF Score™ of 73/100 and a GF Value™ of ¥6.77 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lushang Freda Pharmaceutical Co's institutional ownership is 1.69%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lushang Freda Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lushang Freda Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Lushang Freda Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Lushang Freda Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lushang Freda Pharmaceutical Co Institutional Ownership Chart

Lushang Freda Pharmaceutical Co Historical Data

The historical data trend for Lushang Freda Pharmaceutical Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 1.92 1.92 1.69 1.71 1.71 1.69 1.71 1.70 1.68 1.69
SHSE:600223
73GF Score
Lushang Freda Pharmaceutical Co Ltd SHSE:600223
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lushang Freda Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.69% mean?
Lushang Freda Pharmaceutical Co (SHSE:600223) has a Institutional Ownership of 1.69% as of Aug. 28, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Lushang Freda Pharmaceutical Co and its competitors.
Is Lushang Freda Pharmaceutical Co's Institutional Ownership too high?
Lushang Freda Pharmaceutical Co's current Institutional Ownership is 1.69%. Overall, Lushang Freda Pharmaceutical Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lushang Freda Pharmaceutical Co's Institutional Ownership compare to competitors?
Lushang Freda Pharmaceutical Co's Institutional Ownership of 1.69% can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Real Estate company?
A good Institutional Ownership depends on the Real Estate industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Lushang Freda Pharmaceutical Co and its competitors. Lushang Freda Pharmaceutical Co's current Institutional Ownership is 1.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lushang Freda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co (SHSE:600223) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥6.77, compared to a current price of ¥5.75 — trading 15.1% below its estimated fair value. The current Institutional Ownership is 1.69%. Lushang Freda Pharmaceutical Co's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Lushang Freda Pharmaceutical Co (SHSE:600223), the current Institutional Ownership is 1.69% as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lushang Freda Pharmaceutical Co (SHSE:600223) Overvalued in 2026?

Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥5.75 is trading 15.1% below its estimated GF Value™ of ¥6.77. GuruFocus considers Lushang Freda Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600223:

  • Institutional Ownership: 1.69%
  • GF Value™: ¥6.77 vs. price of ¥5.75 (15.1% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600223 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lushang Freda Pharmaceutical Co Business Description

Address No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
73GF Score

Get the complete analysis for SHSE:600223

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.75
Price
¥6.77
GF Value